chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vomiting; Dizziness; stomach ache/severe stomach pain/Severe stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting), DIZZINESS (Dizziness) and ABDOMINAL PAIN UPPER (stomach ache/severe stomach pain/Severe stomach ache) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products were not provided.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VOMITING (Vomiting), DIZZINESS (Dizziness) and ABDOMINAL PAIN UPPER (stomach ache/severe stomach pain/Severe stomach ache). On 10-Mar-2021, VOMITING (Vomiting), DIZZINESS (Dizziness) and ABDOMINAL PAIN UPPER (stomach ache/severe stomach pain/Severe stomach ache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     Treatment products included milk of magnesia, Buscapina .   Reporter did not allow further contact
Shortness of breath; Fatigue; Fever; Arm pain; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via unspecified route of administration in the left arm, on 17Mar2021 at 13:15 (age at vaccination was 28-year-old), as a single dose for COVID-19 immunisation. Medical history included obesity and allergic to dairy. Concomitant medications included tylenol (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) for an unknown indication received within 2 weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 11:00, patient experienced dizziness, fatigue, fever, and arm pain and on 19Mar2021 experienced shortness of breath. No therapeutic measures were taken for the reported events. The clinical outcome for dizziness, fatigue, fever, arm pain and shortness of breath was not recovered. No follow-up attempts are needed. No further information is expected.
Patient reported cold "like ice" hands & feet, hot body, violent shaking, & vomiting. Pt went to bed and symptoms resolved the next day by 11 AM.
Immediately following inject, pt began to scream/cry. Unable to quiet x 10min; referred to PMD. Cont. w/periods of crying/intermittent quiet periods. No other adverse rxn reported since PMD visit. No fever, local rections noted.
Patient reported feeling well and fully recovered from a recent undisclosed illness. Was due for third Hep B vaccine and requested the seasonal flu vaccination as well.  On Thursday, 1/9/2020, the patient's roommate reported he was hospitalized the evening before.  On Friday 1/10/2020, the patient's roommate reported he was on life support without chance of recovery.
Pt states received vaccine 11/12/2012/ Developed erythematous lesion "large" around vaccine site 11/13/12. Was "hard" & "itchy". On 11/28/12 developed HA & nausea in morning followed by stabbing pain on left flank 4 hrs later. Noted 3 "spots" (vesicular rash) on flank then 11/29 more "spots" occurred - painful. T9 or T10 dermatome. 11/30 zoster-like rash noted by me.
No further AE; GARDASIL 9 given during a temperature excursion.; This spontaneous report has been received from a medical assistant and refers to a patient of unknown age and gender.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 01-SEP-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, during a temperature excursion. (product storage error) (lot number w026152 has been determined to be valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), with an expiration date established as 29-JAN-2025), administered for prophylaxis (strength, and route of administration were not provided). No adverse events were reported.
warm area where vaccine was given; knot where vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No medical history information were provided by the reporter.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given). At the time of the report, VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information were not provided by the reporter..   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021
Pfizer 4/11/21 and 5/2/21. Positive on 1/8/22
PALPITATIONS WHILE STANDING - NEW INCREASED HEART RATE ON STANDING GREATER THAN 30 BEATS PER MINUTE UNSTEADINESS WHILE STANDING/WALKING - NEW BRAIN FOG - WORSENING SINCE JANUARY 2023 FATIGUE - WORSENING SINCE JANUARY 2023  YMPTOMS OF BRAIN FOG AND PAPLIGATIONS HAVE IMPROVED AFTER INCREASING DOSAGE OF CONCERTA FROM 27 TO 36 MG PER DAY AND AFTER ADDING ADDITIONAL SALT AND ELECTROLYTES TO DIET, INCLUDING 1-3 SALT TABS (1000 MG EA) PER DAY.
she developed cellulitis on the left arm after the vaccine was applied; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 05-APR-2019, the patient was vaccinated with shot of zoster vaccine live (ZOSTAVAX) lot # was reported as 27KS5610 with expiration date reported as 10-JUN-2021, , left deltoid at pharmacy (dose, dose number and route of administration were not reported). Lot number 27KS5610 is an invalid lot number for zoster vaccine live.  On 08-APR-2019 reported as 3 days later, the patient returned to store and advised she developed cellulitis on the left arm after the vaccine was applied. On an unknown date in 2019, the patient required medical attention and treatment. The outcome of the event was unknown. The relatedness between the event and zoster vaccine live (ZOSTAVAX) was reported as related.  Upon internal review the event of cellulitis on the left arm was considered to be medically significant.
Pt called 2 days after having received pneumonia vaccine stating that he is having a reaction. Pt states that the left arm is red, hot to the touch, swollen, and painful all at the site of the injection.
Tingling in both her inner thighs; Right ankle started swelling; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non-HCP) from medical information team for a Pfizer sponsored program (004756).  A 16-year-old female patient received bnt162b2 (BNT162B2), administration date 10May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "tingling in both her inner thighs"; JOINT SWELLING (non-serious) with onset 2021, outcome "unknown", described as "right ankle started swelling".  Additional information: The reporter called and asking for medical advice for a 16y/o female patient who received her first dose of the Pfizer BioNTech COVID 19 Vaccine on 10May2021. The patient experienced tingling in both her inner thighs and right ankle started swelling a few moments after vaccine administration. These side effects eventually subsided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Died after taking the vaccine; This is a spontaneous report from a non-contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were Not Provided. The reporter said his cousin died after taking the Covid vaccine and reported as serious due to death. The caller mentioned about that our website or recorded line doesn't say FDA approval and she told him that will be updated by the end of the day and they are aware of that. Reporter then started to say is the president lying and the agent ended the call at that time. Investigation Assessment was Not Provided. It was not reported if Autopsy Done. The outcome of the event was fatal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: died after taking the vaccine
Red quarter-size mark on left leg where VARIVAX given. Rosy cheeks, little diarrhea, Fever 101 degrees (higher at nite). Referred to allergist for testing.
constant fluctuation of burning up; sweating profusely; having chills; headache; diarrhea; dryness of mouth; runny nose; occasional coughing; dizziness; occasional fatigue; This is a spontaneous report from a contactable consumer reporting for herself. A 29-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration from 21Jan2021 09:00 (at the age of 29-years-old) at SINGLE DOSE for covid-19 immunisation.  The patient medical history was not reported.  Concomitant medication included spironolactone, sertraline and bupropion. Prior to vaccination the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in a hospital. On 22Jan2021 11:00, the patient experienced constant fluctuation of burning up, sweating profusely, having chills, headache, diarrhea, dryness of mouth, runny nose, occasional coughing, dizziness and occasional fatigue.   No treatment was received for the events. The events were reported as non-serious. The patient underwent lab tests and procedures which included Rapid Antigen: pending on 24Jan2021. Outcome of the constant fluctuation of burning up, sweating profusely, having chills, headache, diarrhea, dryness of mouth, runny nose, occasional coughing, dizziness and occasional fatigue was not recovered. Since the vaccination, the patient been tested for COVID-19.
Pt complains of rash. Rash has not occurred previously. It is located on the face, chest, and back. Describes rash as pink and papular. Possible contributing factors include IZs on Monday, including MMR.
Employee complained of feeling nauseated, then became pale and fainted.  Fell out of chair onto floor, sustaining abrasion to R upper cheekbone.  Then arms turned inward and became rigid, unresponsive to verbal stimuli, stertorous breathing.  Turned onto L side, 911 called.  Employee then regained consciousness, but remained pale.  Placed in supine position with legs elevated, BP 120/84, P 80, A&O x 3, skin warm and dry.  EMS arrived who transported employee to ER where he was treated and released.
Woke up at 5am and transported to hospital . never regain conciousmess
In her eyes, patient felt tingling and fluttering; we could not see her eyes moving at all.  She also felt tingling in both arms, both hands, her face, and torso; she also had a lot of pain in her back. She felt that her face was hot but to the touch it was not.  After about 20 minutes of these sensations her fingers cramped in gnarled positions that she was unable to straighten. Her right hand fingers was more rigid than her left.  This lasted about 30 minutes and then she was slowly able to straighten her fingers.  By the time she went to bed, around 10 pm, she felt basically back to normal.
Heart Palpitations were going on starting the second week of May then I went to the cardiologist in July that gave me a Holter Monitor that came back with atrial flutter and Non-sustained ventricular tachycardia. I was given an echocardiogram and EKG. Now symptoms are only present when heartbeat is elevated during exercise or excitement, however, it is not during the normal day to day activities.
PT rec'd pfizer (grey cap) after it was stored in freezer for 22 days- rec'd re-vaccination on 6/2/22
Hospitalist Dr.  called inpatient pharmacy at a local Hospital to report that patient has myocarditis and is suspected to be from flu or covid or combo of both received on 10/20/22 at a Clinic.
Passed away after taking the 2 first vaccines covid vaccines; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single, and via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history and concomitant medications were not reported. It was reported that the patient passed away after taking the 2 first vaccines COVID vaccines on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Passed away after taking the 2 first vaccines covid vaccines
swelling under the injection arm after receiving the 1st dose of Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (swelling under the injection arm after receiving the 1st dose of Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy since an unknown date.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling under the injection arm after receiving the 1st dose of Moderna vaccine). At the time of the report, VACCINATION SITE SWELLING (swelling under the injection arm after receiving the 1st dose of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications taken by the patient were not provided. Treatment information was not provided.
This spontaneous report was received from a consumer (patient mother) refers to a 8 year old male patient. The patient had no pertinent medical history and no history of allergy. On an unknown date, around the age of three or four, the patient was vaccinated with ATTENUVAX (dose and frequency were not reported) one dose. Concomitant therapies included MUMPSVAX and MERUVAX II. On an unknown date, the patient experienced broke out with measles, itchiness and fever. On an unknown date, years later, the patient also experienced allergy induced asthma. The consumer stated that the allergy induced asthma would not be related to ATTENUVAX. On an unknown date, the patient underwent some blood test and result showed as would be immune to measles. The patient sought medical attention and visited the office. The patient was treated with Advil. The outcome of the events was reported as recovered. The reporter did not provide the causality between the events wand the suspect drug. Additional information has been requested.
WERE ZOMBIES; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced were zombies. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of were zombies was not reported. This report was non-serious. This case, from the same reporter is linked to 20220141741 and 20220141910.
This spontaneous report was received from a registered nurse regarding unspecified number of patients of unknown age and gender. There was no information or pertinent medical history and drug reactions or allergies. On an unknown date, the patients received less than the recommended dose of VARIVAX (Merck) (dose, route, product lot#, expiry date was not reported). No adverse events were reported. There was no product quality complaint involved. The outcome of the events was unknown. Follow up information has been received from a nurse during a phone call on 07-APR-2015. The nurse provided that vaccination information (dates of vaccination, dose number, lot number) and patient identification information (patient name, date of birth) were not readily available at the time of the call. The nurse provided that there were no adverse events reported following administration of the vaccinations VARIVAX (Merck) and also provided that the patients who received the vaccinations were pediatric patients or "college kids who needed a booster". The nurse stated that the staff "was confused because the product instructions say to draw up 0.5 milliliters but then about 6 paragraphs down, it explained about reconstitution." This is one of the several reports from the same source. Additional information has been requested.
Information has been received from a physician concerning a male patient who in 1999 in vaccinated a 0.5 ml dose of Varivax. On 18-JAN-2007 the patient experienced a breakthrough case of chickenpox. Unspecified medical attention was sought. At the time of this report the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Patient was mistakenly given 0.1ml of the Moderna COVID-19 vaccine by a staff member.  The mistake was recognized on August 4, 2021 and all patients effected were informed.  Patient has since been revaccinated on 8/09/21.
Immediate lethargy resulting in unusual day-time nap; vaccination site sore, red, hot and inflamed and remains tender four days later; irritable mood; loss of appetite, stomach pain, diarrhea.
Paralysis in trunk, upper and lower extremities bilateral. Resolved within 24 hours. Client instructed to notify  PCP.
felt so ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt so ill) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (felt so ill). At the time of the report, ILLNESS (felt so ill) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Dec-2021: Non significant follow up contains no new information
Office visits x 2 - PCP and another office. C/O bilateral foot and leg edema, joint pain and leg weakness within 24 hours after influenza vaccine.
pt recv vax & devel mild case of phlebitis;pt was treated w/bed rest & heating pad;
pt recvd vax 14SEP94;15SEP-noon babysitter informed parents that pt had convuls;pt was blue, unresponsive, drowsy, & vomited;MD visit on 15SEP-pt alert & active;nl PE;23JAN95 MD f/u high fever-had febrile sz;cold/UTI w/sx of fever, cough
Son was immunized on 4/28/03 with the MMR and Varivax vaccinations.  At approximately 11 p.m. of Tuesday, 4/29/03 -- baby began to run a high fever (never had a fever before in his life) of 102 to 103 degrees.  Treated the fever with Tylenol and Motrin (alternately).  Stared alot into space and was at time very restless.  Temperature would not go down to normal, with Tylenol/Motrin would go down to 100 degrees.  Fever continued entire day of Wednesday, and Thursday - took him to doctor on Thursday -- ran bloodwork and everything came back normal. ONLY Nursed him to keep him hydrated -- would not eat (my son has a tremendous appetite and this is very unusual as he loves to eat everything he sees).  Fever dissipated on Friday morning, May 2nd, 2003 and began to have profuse bowel movements -- very runny and smelly. Appetite still not normal. Saturday, May 3rd -- baby began to cry inconsolably at about 11 p.m. - would not nurse and there is nothing we could do to make him feel better.  Our baby is not the baby that we knew prior to the vaccinations.  His behavior is completely different and he is not the happy baby he used to be.  He is very miserable.  My husband just left with him to the Hospital emergency room at midnight.
She did not go for her 2nd shot; back pain; shoulder pain/ Knee pain; arm pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm pain), PRODUCT DOSE OMISSION ISSUE (She did not go for her 2nd shot), BACK PAIN (back pain) and ARTHRALGIA (shoulder pain/ Knee pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain), BACK PAIN (back pain) and ARTHRALGIA (shoulder pain/ Knee pain). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She did not go for her 2nd shot). At the time of the report, PAIN IN EXTREMITY (arm pain), PRODUCT DOSE OMISSION ISSUE (She did not go for her 2nd shot), BACK PAIN (back pain) and ARTHRALGIA (shoulder pain/ Knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported   This case was linked to MOD21-092308 (E2B Linked Report).; Sender's Comments:  MOD21-092308:Husband case